Experimental And Molecular Pathology

Journal Title：Experimental And Molecular Pathology

Under new editorial leadership, Experimental and Molecular Pathology presents original articles on disease processes in relation to structural and biochemical alterations in mammalian tissues and fluids and on the application of newer techniques of molecular biology to problems of pathology in humans and other animals. The journal also publishes selected interpretive synthesis reviews by bench level investigators working at the "cutting edge" of contemporary research in pathology. In addition, special thematic issues present original research reports that unravel some of Nature's most jealously guarded secrets on the pathologic basis of disease.

Research Areas include: Stem cells; Neoangiogenesis; Molecular diagnostics; Polymerase chain reaction; In situ hybridization; DNA sequencing; Cell receptors; Carcinogenesis; Pathobiology of neoplasia; Complex infectious diseases; Transplantation; Cytokines; Flow cytomeric analysis; Inflammation; Cellular injury; Immunology and hypersensitivity; Athersclerosis.

在新的编辑领导下，《实验与分子病理学》刊登了关于与哺乳动物组织和体液的结构和生化变化有关的疾病过程的原创文章，以及关于将分子生物学的新技术应用于人类和其他动物的病理学问题的原创文章。该杂志还发表了由在当代病理学研究“前沿”工作的实验室级研究人员撰写的精选解释性综合评论。此外，特别专题刊登了原创研究报告，揭示了自然界关于疾病病理基础的一些最严加保守的秘密。

研究领域包括：干细胞；新血管生成；分子诊断；聚合酶链反应；原位杂交；DNA测序；细胞受体；致癌作用；肿瘤病理生物学；复杂传染病；移植；细胞因子；流式细胞分析；炎症；细胞损伤；免疫学和超敏反应；动脉粥样硬化。

Experimental And Molecular Pathology创刊于1962年，由Academic Press Inc.出版商出版，收稿方向涵盖医学 - 病理学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度 约4.5月 约11.5周，影响因子指数2.8，该期刊近期被列入国际期刊预警名单，请广大学者慎重选择。